These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 3541758)
21. [Chilblain lupus erythematosus. A case report]. Brado B; Keilholz U; Tilgen W; Pezzutto A; Gissler M; Hunstein W Internist (Berl); 1992 Oct; 33(10):701-3. PubMed ID: 1428687 [No Abstract] [Full Text] [Related]
22. [Differentiation of lupus erythematosus and lymphocytic infiltration]. Bonczkowitz M; Weyers W Verh Dtsch Ges Pathol; 1996; 80():235-40. PubMed ID: 9065018 [TBL] [Abstract][Full Text] [Related]
23. Autoimmunity and laboratory testing for systemic lupus erythematosus (SLE) and allied diseases. Deodhar SD Lab Res Methods Biol Med; 1983; 8():89-100. PubMed ID: 6358749 [TBL] [Abstract][Full Text] [Related]
24. Direct immunofluorescence patterns in clinically healthy skin of patients with collagen diseases. Velthuis PJ; Kater L; Baart de la Faille H Clin Dermatol; 1992; 10(4):423-30. PubMed ID: 1303807 [No Abstract] [Full Text] [Related]
29. [Descriptive and comparative study of technical methods used for the detection of antinuclear antibodies]. Abuaf N Ann Biol Clin (Paris); 1982; 40(2):65-74. PubMed ID: 6812470 [TBL] [Abstract][Full Text] [Related]
30. [Anti-nDNA antibodies in lupus erythematosus]. Cardo PP; Robert E; Persi A; Nunzi E G Ital Dermatol Venereol; 1989 Jun; 124(6):253-5. PubMed ID: 2630430 [TBL] [Abstract][Full Text] [Related]
31. Significance of antinuclear factor in the connective tissue diseases. Rowell NR; Beck JS Ann Rheum Dis; 1970 Mar; 29(2):201-2. PubMed ID: 4393304 [No Abstract] [Full Text] [Related]
32. [Subacute cutaneous lupus erythematosus with positive anti SS-B antibody in the aged]. Matsumura A; Mitsumori T; Yoshida T; Akizuki M Nihon Naika Gakkai Zasshi; 1994 Oct; 83(10):1820-1. PubMed ID: 7814958 [No Abstract] [Full Text] [Related]
33. [Anti-DNA antibodies: comparison between the Crithidia luciliae technic and radioimmunoassay (Farr's technic)]. Pigrau C; Ruibal A; Clotet B; Pahissa A; Lience E; Guardia J Med Clin (Barc); 1984 Mar; 82(8):349-53. PubMed ID: 6371402 [No Abstract] [Full Text] [Related]
34. [The use of autologous or normal skin and fluorescein-labelled anti-C3 serum to increase the sensitivity of immunofluorescence reaction to detect antinuclear antibodies []. Vázquez-Escobosa C; Gómez-Estrada H Rev Invest Clin; 1982; 34(2):125-8. PubMed ID: 6750732 [No Abstract] [Full Text] [Related]
35. [Incidence of antinuclear factors, studied by immunofluorescence, of 563 blood samples of subjects with collagen diseases and other disease states]. Del Giacco GS; Mignone V; Davoli C; Novi C Reumatismo; 1966; 18(3):146-50. PubMed ID: 5338008 [No Abstract] [Full Text] [Related]
39. Pathogenesis of connective tissue disease. Holborow EJ Trans Ophthalmol Soc U K (1962); 1974 Sep; 94(3):712-20. PubMed ID: 4282889 [No Abstract] [Full Text] [Related]